Sanaby Health Acquisition Corp. I
Liquidated 2022-10-20- CIK 1856689
- SANB
- IPO 2021-10-18
- $175M trust
- 38 filings
- IPO Size
- $173M
- raised at the IPO
- Trust
- $175M
- as of 2022-06-30
- Current Status
- Failed
- from its latest filing
- IPO Year
- 2021
- year it listed
Filings, by quarter
38 filings over 7 quarters; violet bars carry a milestone
- 21 Q2: 1 filing
- 21 Q3: 2 filings
- 21 Q4: 24 filings
- 22 Q1: 6 filings
- 22 Q2: 1 filing
- 22 Q3: 1 filing
- 22 Q4: 3 filings
- S-1 filed 21 Q2
- IPO 21 Q4
- Liquidated 22 Q4
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Sanaby Health Acquisition Corp. I is a blank-check company seeking to complete a business combination. Its stated focus is healthcare, particularly digital health, life science tools and services, innovative treatment developers, and therapeutics including digital therapeutics.
Investment Focus
Healthcare, Biopharmaceuticals
Key Information
As the filings state it
- IPO Date
- 2021-10-18
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Failed Date
- 2022-10-20
- SPAC Ticker
- SANB
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
Led by founder and CEO Sandra Shpilberg, a healthcare entrepreneur, biotech executive and active investor with M&A experience; the team also includes healthcare and biopharma operators Mark Joing, Timothy Zanni, Anthony Japour and Barbara Nelsen, with experience spanning clinical operations, life sciences, finance, biotech and healthcare investments.